Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea
Launched by OSMANIYE KORKUT ATA UNIVERSITY · Dec 16, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of Transcutaneous Electrical Nerve Stimulation, or TENS, to help manage pain and other symptoms associated with primary dysmenorrhea, which is severe menstrual pain. The goal is to see if TENS can reduce the intensity of this pain and improve overall comfort during menstruation. TENS is a safe, non-invasive method that uses electrical impulses to stimulate nerves and relieve pain without medication.
To participate in this study, women aged 18 and older who experience moderate to severe menstrual pain (rated 4 or higher on a pain scale) and have regular menstrual cycles may be eligible. However, women who have certain conditions, like secondary dysmenorrhea, are currently taking birth control pills, or have had previous experience with TENS will not be included. If you decide to participate, you can expect to receive TENS treatment and share your experiences regarding pain levels and menstrual symptoms, contributing valuable information about potential new ways to manage dysmenorrhea.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Aged 18 and above
- • Have regular menstrual cycles (lasting 3 to 8 days, with a menstrual cycle range of 21 to 35 days)
- • Have dysmenorrhea pain severity rated 4 or higher on the Visual Analog Scale (VAS)
- Exclusion Criteria: Women with the following conditions were excluded from the study:
- • Secondary dysmenorrhea
- • Using oral contraceptives
- • Having impaired tissue integrity in the abdominal area
- • Having previous experience with TENS
- • Having a history of nerve damage or sensory loss
- • Having a pacemaker
- • Having any systemic diseases
- • Being pregnant or in the postpartum period
About Osmaniye Korkut Ata University
Osmaniye Korkut Ata University is a leading academic institution dedicated to advancing research and education in the field of health sciences. As a clinical trial sponsor, the university emphasizes rigorous scientific inquiry and ethical standards, fostering collaborations that enhance the development of innovative therapeutic interventions. With a focus on improving patient outcomes and public health, the university leverages its multidisciplinary expertise and state-of-the-art facilities to support clinical research initiatives that address pressing health challenges. Through its commitment to excellence, Osmaniye Korkut Ata University aims to contribute significantly to the global body of medical knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Osmaniye, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported